January 26, 2025 - 16:00

Rajat Soni, a finance industry expert with over a decade of experience, has voiced strong opinions against the adoption of Ripple's cryptocurrency, XRP, by financial institutions. Soni argues that while XRP has potential, the complexities surrounding regulatory compliance and the existing banking infrastructure may hinder its widespread acceptance.
He emphasizes that banks are traditionally cautious when it comes to integrating new technologies, particularly those that involve digital currencies. Soni points out that many financial institutions are still navigating the implications of cryptocurrency regulations and are wary of the volatility associated with digital assets.
Furthermore, he highlights the importance of trust and stability in banking, suggesting that institutions may prefer to develop their own digital currencies rather than rely on third-party solutions like XRP. As the financial landscape continues to evolve, Soni's insights reflect a growing skepticism about the immediate future of XRP within the banking sector. The ongoing dialogue around cryptocurrency adoption remains a critical issue for financial institutions worldwide.
March 17, 2026 - 05:46
Virginia joins multi-state lawsuit against OneMain FinancialVirginia has officially joined a coalition of a dozen states in filing a lawsuit against OneMain Financial, a major consumer loan company. The legal action, announced by Attorney General Jay Jones,...
March 16, 2026 - 02:28
Barclays Lifts PT on EOG Resources (EOG) to $140 From $133In a recent move underscoring confidence in the energy sector, investment bank Barclays has increased its price target for EOG Resources, Inc. The firm lifted its target to $140 per share, up from...
March 15, 2026 - 05:53
Peak War Panic Predicted to Grip Markets Within WeeksA leading market strategist warns that global financial markets are likely to experience a peak period of war-induced panic within the next one to three weeks. This forecast comes as both the...
March 14, 2026 - 22:13
A Look At Afya (NasdaqGS:AFYA) Valuation After Recent Mixed Share Price PerformanceThe valuation of Brazilian medical education leader Afya is under scrutiny following a period of mixed performance for its shares. While the stock experienced a modest single-day gain of...